Yoshihiro Imaeda Selected Research

Therapeutics

4/2018	[Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report].
12/2009	Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Imaeda Research Topics

Disease

6	Neoplasms (Cancer) 08/2014 - 10/2003
5	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2003
2	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 10/2005
1	Adenocarcinoma 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022
1	Leiomyosarcoma 08/2014
1	Rhabdomyosarcoma 08/2014
1	Carcinosarcoma 08/2014
1	Stomach Neoplasms (Stomach Cancer) 10/2005
1	Breast Neoplasms (Breast Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

4	Cimetidine (Biomet)FDA LinkGeneric 12/2009 - 10/2003
3	E-SelectinIBA 12/2009 - 10/2005
1	MucinsIBA 11/2022
1	trifluridine tipiracil drug combinationIBA 04/2018
1	Bevacizumab (Avastin)FDA Link 04/2018
1	AntigensIBA 12/2009
1	ErbB Receptors (EGF Receptor)IBA 06/2008
1	EpitopesIBA 10/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2018 - 10/2005
2	Therapeutics 04/2018 - 12/2009
1	Metastasectomy 06/2020
1	Operative Surgical Procedures 08/2014
1	Cytoreduction Surgical Procedures 08/2014
1	Radiotherapy 06/2008